Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
My Custom Filters
Edit custom filtersCited In for PMID: 40156952
2 results
Filters applied: . Clear all
Page 1
Pharmacological characterization of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR4.
Mol Pharmacol. 2025 Apr;107(4):100015. doi: 10.1016/j.molpha.2025.100015. Epub 2025 Jan 31.
Mol Pharmacol. 2025.
PMID: 40156952
Free article.
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.
Mobach S, Bergkamp ND, Ma Z, Haselager MV, Anbuhl SM, Jurriens D, van den Bor J, Wang Z, Crudden C, Roos JL, Perez Almeria CV, Boergonje RA, Lohse MJ, Bosma R, Eldering E, Siderius M, Wu W, Spaargaren M, Tonino SH, Kater AP, Smit MJ, Heukers R.
Mobach S, et al.
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2424186122. doi: 10.1073/pnas.2424186122. Epub 2025 Jun 11.
Proc Natl Acad Sci U S A. 2025.
PMID: 40498456
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.